Pfizer struggles to find new revenue sources as vaccine sales fade, but here’s why investors shouldn’t shy away from its stock
- Posted on November 4, 2024
- By The Globe and Mail
- 1 Views
Pfizer struggles to find new revenue sources as vaccine sales fade, but here’s why investors shouldn’t shy away from its stock
However, don’t expect big immediate gains
